Target intelligence / Profile preview

Egg-derived glycan

Molecular classification
Other (glycan/carbohydrate structure), N-glycan, O-glycan
01

Overview

Egg-derived glycans are complex carbohydrate structures attached to proteins (glycoproteins) found in avian eggs, notably chicken egg white and yolk. They include both N-glycans and O-glycans, which contribute to protein stability, folding, and immune recognition[2][3][5]. Some of these glycans, such as sulfated N-acetyllactosamine, have been shown to act as immunologically relevant antigens, particularly when egg components are used in vaccine production, eliciting immune responses—sometimes undesirable—in humans[7]. In reproductive biology, specific O- and N-glycans on proteins in the egg coat (zona pellucida) play roles in sperm–egg binding and species specificity of fertilization[4][5]. Glycan heterogeneity, such as differences in α-galactosylation or sialylation, is noted between species and even within egg components, with implications for cross-species compatibility and antigenicity[1][2][3]. Egg-derived glycans do not represent a conventional drug target (enzyme, receptor, transporter, etc.), but rather a heterogeneous class of biological modifications with roles in protein function and immunology. The category "egg-derived glycans" is too broad and nonspecific to map onto a single canonical molecular target suitable for structured therapeutic characterization. If you require mapping for a specific glycan (e.g., sulfated N-acetyllactosamine, ovomucoid glycan), it is best to specify that epitope or structure.

Other names
Egg white glycanEgg yolk glycanEgg N-glycanEgg O-glycanEgg sulfated N-acetyllactosamine
02

Mechanism of action

Not applicable

03

Biological functions

Structural modification of proteinsRegulation of protein folding and stabilityImmune recognition and modulationMediation of species-specific interactions (e.g., sperm-egg binding)
04

Disease associations

Vaccine-related immune modulation (anti-glycan antibody response)Potential allergy (egg protein and glycan-related immune phenomena)Other
05

Safety considerations

Egg-grown vaccines can induce anti-glycan antibodies that may act as antigenic decoys, diverting immune responses away from protective antigensRisk of allergy or hypersensitivity to egg components in biopharmaceuticals
06

Biomarkers

Anti-egg glycan antibodies (for immunogenicity and vaccine studies)

Beyond the preview

Go deeper on Egg-derived glycan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Egg-derived glycan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call